PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 23 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

13 January 2026

  1. (diff | hist) 02:07 Arcuate nucleus 5,251 ±0 Chromatokid (talk | contribs) the article treated a rodent finding as human physiology; corrected [rollback]

12 January 2026

  1. (diff | hist) m b 12:19 Peptide 6,813 ±0 CiteBot (talk | contribs) bot: sort category members [rollback]
  2. (diff | hist) 12:18 Talk:Semaglutide 611 +173 ForestPlotFinn (talk | contribs) /* Weight-loss figure in the lead */ reply
  3. (diff | hist) 09:40 Talk:Semaglutide 400 +214 SemaglutideSasha (talk | contribs) /* Weight-loss figure in the lead */ new section
  4. (diff | hist) m b 07:21 Deamidation 5,263 ±0 ArchiveBot (talk | contribs) bot: flag bare reference [rollback]
  5. (diff | hist) m 02:13 Survodutide 5,445 ±0 SPPS_Sorrel (talk | contribs) add the peptide length to the infobox [rollback]
  6. (diff | hist) m 00:57 Injection site rotation 4,872 ±0 MissedDoseMik (talk | contribs) add the disclaimer that this is not administration guidance [rollback]

11 January 2026

  1. (diff | hist) 21:23 Beta cell function 6,096 ±0 DPP4_Dagmar (talk | contribs) ce per PP:MOS [rollback]
  2. (diff | hist) m b 21:14 GenScript Peptides 14,017 +1,947 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  3. (diff | hist) 16:30 Grey market 4,279 ±0 SPPS_Sorrel (talk | contribs) convert a hard-coded date to the house format [rollback]
  4. (diff | hist) 12:55 Talk:High-performance liquid chromatography 611 +191 Areapercent_Ayo (talk | contribs) /* A clean trace is evidence about what was detected */ reply
  5. (diff | hist) 09:20 Talk:High-performance liquid chromatography 400 +123 Chromatokid (talk | contribs) /* A clean trace is evidence about what was detected */ new section
  6. (diff | hist) m 08:12 Bachem Holding (Suzhou) 15,124 +220 GroupBuyGalen (talk | contribs) expand §Product range [rollback]
  7. (diff | hist) 07:13 Glucagon-like peptide-1 12,294 ±0 BiosimilarBoaz (talk | contribs) add category for receptor pharmacology [rollback]
  8. (diff | hist) m 04:17 Intention-to-treat analysis 4,963 ±0 BlindSampleBrid (talk | contribs) expand §Missing data [rollback]

10 January 2026

  1. (diff | hist) m 23:07 Reconstitution calculator 8,662 ±0 EndotoxinEd (talk | contribs) add the caveat that concentration and dose are not the same quantity [rollback]
  2. (diff | hist) 21:59 Sarcopenia 4,491 ±0 UnitsUrsula (talk | contribs) correct the decimal place in the conversion factor [rollback]
  3. (diff | hist) 19:47 Triple agonist 4,269 ±0 SurvodutideSaff (talk | contribs) correct the molar mass — source gives the free-base figure, we had the salt [rollback]
  4. (diff | hist) m b 12:42 Medutest 5,018 ±0 ArchiveBot (talk | contribs) bot: update parent category chain [rollback]
  5. (diff | hist) 10:45 Shenzhen Hybio Pharmaceutical 14,454 +478 LedgerLysander (talk | contribs) attribute the documentation description to the purchaser reports it comes from [rollback]
  6. (diff | hist) 09:04 Talk:Syringe dead space 1,244 +128 DeadSpaceDot (talk | contribs) /* The 35% figure is being cited elsewhere as an unconditional dose error */ reply
  7. (diff | hist) 09:02 Talk:Insulin syringe unit conversion 822 +157 GramsNotUnitsGil (talk | contribs) /* Is the U-40 material needed at all? */ reply
  8. (diff | hist) 08:12 Talk:Glucagon 1,096 +60 GIP_Genoveva (talk | contribs) /* GIP and glucagon secretion — contradiction with the GIP article? */ reply
  9. (diff | hist) m 06:56 AmbioPharm 11,766 +457 SecondarySrc_Seb (talk | contribs) fix a dangling clause [rollback]
  10. (diff | hist) m 04:46 PolyPeptide Group (Hangzhou) 14,476 +61 SemaglutideSasha (talk | contribs) expand §Distribution and dispatch [rollback]
  11. (diff | hist) m 02:50 Peptide synthesis 5,649 ±0 CDMO_Caradoc (talk | contribs) give the vial sizes in millilitres of nominal capacity [rollback]
  12. (diff | hist) m b 01:20 Limit of detection 4,865 ±0 CategoryBot (talk | contribs) bot: normalise unit spacing [rollback]
  13. (diff | hist) m 01:04 Bacteriostatic water 4,652 ±0 BUD_Bertram (talk | contribs) clarify that the figure is per dose, not per vial [rollback]

9 January 2026

  1. (diff | hist) 18:02 Peptide harm reduction 4,800 ±0 CostPerMgCory (talk | contribs) add the prior-authorisation criterion as attributed to the payer document [rollback]
  2. (diff | hist) 17:33 Talk:Syringe dead space 1,033 +324 NurseNoteNessa (talk | contribs) /* The 35% figure is being cited elsewhere as an unconditional dose error */ reply
  3. (diff | hist) 15:28 Talk:Insulin syringe unit conversion 611 +401 UnitsUrsula (talk | contribs) /* Is the U-40 material needed at all? */ reply
  4. (diff | hist) m 13:47 Adverse effects of GLP-1 receptor agonists 5,791 ±0 AnaesthesiaAoife (talk | contribs) close an unbalanced quotation mark [rollback]
  5. (diff | hist) m b 13:27 Cold-chain freight 4,758 ±0 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  6. (diff | hist) 12:47 Talk:Glucagon 885 +162 IncretinIvo (talk | contribs) /* GIP and glucagon secretion — contradiction with the GIP article? */ reply
  7. (diff | hist) 12:11 Talk:Insulin syringe unit conversion 400 +420 GramsNotUnitsGil (talk | contribs) /* Is the U-40 material needed at all? */ new section
  8. (diff | hist) 10:39 Contraindications of incretin therapy 4,993 ±0 Chromatokid (talk | contribs) add the contraindication with its rationale [rollback]
  9. (diff | hist) 09:33 Talk:Glucagon 674 +190 GIP_Genoveva (talk | contribs) /* GIP and glucagon secretion — contradiction with the GIP article? */ new section
  10. (diff | hist) 08:45 Talk:Third-party testing 822 +111 ReportReaderRilla (talk | contribs) /* The three questions */ reply
  11. (diff | hist) 05:57 WuXi TIDES 16,434 ±0 GradientGus (talk | contribs) add the standing talk-page note link to the banner [rollback]

8 January 2026

  1. (diff | hist) 23:22 Dose escalation schedule 4,993 ±0 Chromatokid (talk | contribs) add the shelf life after first puncture, attributed [rollback]
  2. (diff | hist) 17:28 Sigma-Aldrich (Shanghai) Trading 18,421 +1,133 ComparisonCato (talk | contribs) clarify that no manufacturing or marketing authorisation is claimed or established [rollback]
  3. (diff | hist) m 15:08 Multi-dose vial 23,705 ±0 BUD_Bertram (talk | contribs) close an unbalanced quotation mark [rollback]
  4. (diff | hist) 13:10 Talk:Third-party testing 611 +111 VerifyVesna (talk | contribs) /* The three questions */ reply
  5. (diff | hist) 09:51 Baseline laboratory panel 4,429 ±0 LipidLedgerLou (talk | contribs) add the cross-link to the organ-function article [rollback]
  6. (diff | hist) 09:30 Talk:Third-party testing 400 +205 COA_Colwyn (talk | contribs) /* The three questions */ new section
  7. (diff | hist) 08:28 Prior authorisation 4,216 ±0 AppealsArno (talk | contribs) serial comma per PP:MOS [rollback]
  8. (diff | hist) 08:28 Sterile water for injection 4,738 ±0 ColdChainCleo (talk | contribs) add the preservative point: unpreserved diluent changes the interval [rollback]
  9. (diff | hist) 05:10 Wuhan Wansheng Biotechnology 15,849 ±0 VerifyVesna (talk | contribs) add the reception tally with its period and count stated [rollback]
  10. (diff | hist) 04:27 C-peptide 4,400 ±0 ApoB_Aurelio (talk | contribs) split the analytical performance from the clinical interpretation [rollback]
  11. (diff | hist) 00:54 ISO 9001 4,278 ±0 CaptionCzeslaw (talk | contribs) correct the agency abbreviation at first use [rollback]

7 January 2026

  1. (diff | hist) m b 23:47 Dual incretin agonist 5,851 ±0 CategoryBot (talk | contribs) bot: sort category members [rollback]
  2. (diff | hist) 21:40 Janoshik Analytical 5,235 ±0 UnitsUrsula (talk | contribs) fix a dangling clause [rollback]
  3. (diff | hist) m 16:08 Amylin receptor agonist 5,245 ±0 LiraLotte (talk | contribs) ce, tighten prose [rollback]
  4. (diff | hist) 14:59 Drug master file 4,325 ±0 BPC_Bramwell (talk | contribs) add category for drug regulation [rollback]
  5. (diff | hist) 10:26 Insulin secretion 6,940 ±0 SigFigSindri (talk | contribs) add a figure for the secretion time course and caption it [rollback]
  6. (diff | hist) m 03:03 SELECT trial 5,171 ±0 BPC_Bramwell (talk | contribs) expand §Design [rollback]
  7. (diff | hist) m 02:33 Reconstitution of lyophilised peptides 5,761 ±0 DrTitration (talk | contribs) add the note about drawing air before withdrawal [rollback]

6 January 2026

  1. (diff | hist) m 20:39 Qingdao Saber Technology Pharmaceutical 12,198 ±0 ApoB_Aurelio (talk | contribs) state what the certificate supplied with orders carries [rollback]
  2. (diff | hist) m 17:48 Patent expiry and biosimilars 4,553 ±0 PreregPriya (talk | contribs) add the customs-detention point with its source [rollback]
  3. (diff | hist) 17:23 Temperature excursion 22,977 +858 SPPS_Sorrel (talk | contribs) the article confused primary and secondary drying; corrected [rollback]

5 January 2026

  1. (diff | hist) m 20:11 Third-party testing 7,489 ±0 UnderfillUna (talk | contribs) add the cross-link to the traceability article [rollback]
  2. (diff | hist) 16:36 Lot traceability 5,317 ±0 AxisLabelAgda (talk | contribs) add the difference between a batch certificate and a lot-specific one [rollback]
  3. (diff | hist) 13:25 Shanghai Wibson Biotechnology 15,440 ±0 AnalyticalAnnie (talk | contribs) add the how-to-request-a-batch-record sentence to §Ordering and availability [rollback]
  4. (diff | hist) 13:12 Contract development and manufacturing organisation 5,011 ±0 BaselineBex (talk | contribs) the article confused primary and secondary drying; corrected [rollback]
  5. (diff | hist) m 07:00 Hypoglycaemia 4,473 ±0 ChromCleanupCass (talk | contribs) add the pregnancy statement as attributed to the labelling [rollback]
  6. (diff | hist) 02:36 Bacterial endotoxin test 5,317 ±0 OrforglipronOona (talk | contribs) correct the integration description — valley-to-valley, not drop-line [rollback]
  7. (diff | hist) 02:17 Oral semaglutide 4,582 ±0 TirzTaxonomist (talk | contribs) expand §Clinical position [rollback]

4 January 2026

  1. (diff | hist) 23:52 Dipeptidyl peptidase-4 7,022 ±0 HyphenHarriet (talk | contribs) move the trial material out of §Physiology into the compound articles [rollback]
  2. (diff | hist) m 21:38 Custom peptide synthesis 4,773 ±0 Hedgerow_Hal (talk | contribs) add the shelf temperature and the primary drying step to the cycle description [rollback]
  3. (diff | hist) m 20:56 Chain of custody 5,157 ±0 LipidLedgerLou (talk | contribs) de-orphan [rollback]
  4. (diff | hist) m b 20:18 Exenatide 5,754 ±0 StubSorterBot (talk | contribs) bot: expand DOI to full citation [rollback]
  5. (diff | hist) 17:17 Residual solvent 5,085 ±0 AAA_Analyst (talk | contribs) sentence case in headings per PP:MOS [rollback]
  6. (diff | hist) 06:10 Cost per milligram 4,125 ±0 FmocFrancis (talk | contribs) split §Pricing from §Coverage [rollback]
  7. (diff | hist) 05:18 Glucose-dependent insulinotropic polypeptide 8,265 ±0 BetaCellBoyd (talk | contribs) add the species in which the knockout work was done [rollback]
  8. (diff | hist) 04:30 Personal importation policy 4,121 ±0 Chromatokid (talk | contribs) add the note that a certificate of analysis has no regulatory standing [rollback]

3 January 2026

  1. (diff | hist) 20:56 Vial 25,946 ±0 SPPS_Sorrel (talk | contribs) rm the blanket claim that excursions are harmless [rollback]
  2. (diff | hist) m 20:01 Syringe dead space 16,549 +662 SeeAlsoSelma (talk | contribs) convert the conversion list to a table so the three syringe scales align [rollback]
  3. (diff | hist) 13:48 Guangzhou JEEP Biotechnology 15,452 +220 ChainCustodyChad (talk | contribs) sentence case in headings per PP:MOS [rollback]
  4. (diff | hist) 08:42 Retatrutide 7,421 ±0 AnalyticalAnnie (talk | contribs) add the excipient list from the labelling [rollback]
  5. (diff | hist) 05:12 Gastric emptying 5,565 ±0 ExternalLinksEli (talk | contribs) the article treated a rodent finding as human physiology; corrected [rollback]
  6. (diff | hist) m 01:44 Placebo-adjusted effect 4,805 ±0 TrialsTabitha (talk | contribs) add the missing-data handling method [rollback]

2 January 2026

  1. (diff | hist) 22:03 MOTS-c 4,670 ±0 CDMO_Caradoc (talk | contribs) give the counterion, since it changes the mass by several per cent [rollback]
  2. (diff | hist) m 17:28 USP General Chapter 71 4,657 ±0 LOD_Lorcan (talk | contribs) ce, tighten prose [rollback]
  3. (diff | hist) m 16:01 Beyond-use date 23,108 ±0 CarryOverCai (talk | contribs) expand §Sterile preparations under USP <797> [rollback]
  4. (diff | hist) m 09:42 Melanotan II 4,649 ±0 EpitalonEoin (talk | contribs) the lead said "widely used"; replaced with what the sources actually support [rollback]
  5. (diff | hist) 07:08 AmbioPharm 11,309 ±0 RotationRosalind (talk | contribs) add the storage and handling guidance the organisation publishes [rollback]
  6. (diff | hist) m 06:19 Solid-phase peptide synthesis 5,359 ±0 ResinRhoswen (talk | contribs) move a stray full stop inside the reference [rollback]
  7. (diff | hist) 04:32 Xi'an Mokemei Biotechnology 14,699 +1,086 VerifyVesna (talk | contribs) rm the comparison with another supplier; there is no common basis for it [rollback]
  8. (diff | hist) 04:18 Blind sampling 8,193 ±0 Chromatokid (talk | contribs) clarify that a QR code on a certificate proves issuance, not content [rollback]
  9. (diff | hist) m b 02:29 SinoPep 15,567 ±0 CategoryBot (talk | contribs) bot: sort category members [rollback]

1 January 2026

  1. (diff | hist) 23:53 Customs seizure 4,785 ±0 EmptyingElke (talk | contribs) expand §How a consignment is handled [rollback]
  2. (diff | hist) 21:08 Cold chain 27,150 ±0 Retention_Time_Rae (talk | contribs) clarify that the cake appearance is an indicator, not a specification [rollback]
  3. (diff | hist) 16:00 Shanghai ERP Biotechnology 12,013 +1,773 COA_Colwyn (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  4. (diff | hist) 12:03 Certificate of analysis 10,014 ±0 COA_Colwyn (talk | contribs) state what the certificate actually carries, field by field [rollback]
  5. (diff | hist) m 06:03 Global access disparity 4,391 ±0 CostPerMgCory (talk | contribs) add the year each price figure refers to [rollback]
  6. (diff | hist) 05:26 GenScript Peptides 12,070 ±0 UnderfillUna (talk | contribs) add the reception tally with its period and count stated [rollback]
  7. (diff | hist) m 01:24 Reverse-phase HPLC 5,499 ±0 NauseaNoor (talk | contribs) add the forced-degradation conditions the claim rests on [rollback]

31 December 2025

  1. (diff | hist) 22:22 GL Biochem (Shanghai) 16,491 ±0 GHK_Gwendolen (talk | contribs) convert the product range to a table so the documentation column lines up [rollback]
  2. (diff | hist) 21:37 Flourishglobal Peptide Biotech 14,034 +860 StubExpanderSven (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]
  3. (diff | hist) m 19:33 Number needed to treat 4,718 ±0 OrforglipronOona (talk | contribs) correct the endpoint hierarchy — that was a secondary endpoint [rollback]